2014
Feasibility and Tolerability of Quantitative Sensory Testing in Patients with Sickle Cell Disease at the End of a Vasoocclusive Episode
Bakshi N, Lukombo I, Belfer I, Krishnamurti L. Feasibility and Tolerability of Quantitative Sensory Testing in Patients with Sickle Cell Disease at the End of a Vasoocclusive Episode. Blood 2014, 124: 3519. DOI: 10.1182/blood.v124.21.3519.3519.Peer-Reviewed Original ResearchVaso-occlusive episodesQuantitative sensory testingSickle cell diseaseSensory testingCell diseaseVasoocclusive episodesPain intensityAcute vaso-occlusive episodesQST proceduresMapi Research TrustPain Catastrophizing ScalePain Coping InventoryChildren's Somatization InventoryMedian ageChronic painPain interferencePain sensitivityPatient preferencesPain stimuliPain unpleasantnessCold painPROMIS measuresPatient's requestDepressive symptomsThermal pain
2013
Catastrophizing and Depression Are Associated With a Poorer Quality Of Life In Pediatric Patients With Sickle Cell Disease
Bakshi N, Lukombo I, Shnol H, Mittal N, Joshi S, Belfer I, Krishnamurti L. Catastrophizing and Depression Are Associated With a Poorer Quality Of Life In Pediatric Patients With Sickle Cell Disease. Blood 2013, 122: 1706. DOI: 10.1182/blood.v122.21.1706.1706.Peer-Reviewed Original ResearchSickle cell diseaseVaso-occlusive crisisQuantitative sensory testingPain Catastrophizing ScaleLife scoresSignificant negative correlationPsychological covariatesPediatric patientsCell diseaseDepression scoresTotal scoreMapi Research TrustMedian hemoglobin levelEmergency room visitsMedian depression scorePain Coping InventoryPediatric Pain Coping InventoryNegative correlationQuality of lifeGeneric QoL scalesImportant therapeutic targetExperience of painMedian total scoreChildren's Somatization InventoryPeds QL